Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from stealth mode and collaboration with ...

H, three teams of researchers have regrown bone and cartilage, even entire knees, in animal studies. Human trials are not far ...

Zoetis offers broad diversification across animal health products, with nearly equal U.S. and international revenue exposure.

The ENLIGHTEN-4 Phase 3 program from Eli Lilly and Co. tests a new weekly shot, eloralintide, in adults who have knee osteoarthritis pain and are overweight or have obesity. The goal is to see if this ...

IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...

A new medication designed to relieve knee pain in osteoarthritis has shown significant promise in an international clinical tria ...

Episcopal Health Services announced on Tuesday, March 24, that it is now offering low-dose radiotherapy using its new ...

On March 23, 2026, Enlivex announced that the U.S. Food and Drug Administration cleared its Investigational New Drug application for Allocetra to treat moderate-to-severe age-related primary knee ...

Enlivex’s first regulatory approval for a late-stage global Phase 2b study in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis ...

Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...

Share on Pinterest A new study found that semaglutide benefits extend beyond weight loss by easing osteoarthritis symptoms. Tatsiana Volkava/Getty Images A new study reports that GLP-1 semaglutide ...

Infrapatellar fat pad glucocorticoid injections were ineffective for pain relief and joint effusion in patients with knee osteoarthritis. Injecting infrapatellar fat pad steroids does not ...